Clozapine in Schizophrenia and Its Association with Treatment Satisfaction and Quality of Life: Findings of the Three National Surveys on Use of Psychotropic Medications in China (2002–2012)
Qian Li,Yu-Tao Xiang,Yun-Ai Su,Liang Shu,Xin Yu,Christoph U. Correll,Gabor S. Ungvari,Helen F. K. Chiu,Cui Ma,Gao-Hua Wang,Pei-Shen Bai,Tao Li,Li-Zhong Sun,Jian-Guo Shi,Xian-Sheng Chen,Qi-Yi Mei,Ke-Qing Li,Tian-Mei Si,John M. Kane
DOI: https://doi.org/10.1016/j.schres.2015.07.048
IF: 4.662
2015-01-01
Schizophrenia Research
Abstract:Objective: We examined the time trends and correlates of clozapine use in schizophrenia patients in China.Method: A total of 14,013 patients with schizophrenia treated in 45 psychiatric hospitals/centers nationwide were interviewed in 2002, 2006 and 2012. Patients' socio-demographic and clinical characteristics including psychopathology, medication side effects, satisfaction with treatment and quality of life (QOL) were recorded in a standardized fashion.Results: Clozapine was used in 32.9% of the whole sample; with corresponding figures of 39.7%, 32.5% and 26.4% in 2002, 2006 and 2012 (p < 0.001). Families of clozapine users had lower satisfaction with treatment than those of the non-clozapine group, without significant differences with respect to patients' treatment satisfaction and mental or physical QOL. In multiple logistic regression analyses, compared to the non-clozapine group, patients on clozapine had an earlier age of onset, longer illness duration, more global illness severity and drug-induced central nervous system, gastrointestinal and other side effects, lower antipsychotic doses, less delusions and hallucinations, more negative symptoms, were more likely male, inpatients, to have a family history of psychiatric disorders, receive treatments in regional centers and receive antipsychotic polypharmacy, but less likely to have health insurance and receive first-generation antipsychotics and benzodiazepines (R-2 = 0.498, p < 0.001).Conclusions: Clozapine was used in one-third of schizophrenia patients in China, with decreasing frequency since 2002. Patients prescribed clozapine had multiple markers of greater global illness severity/chronicity and decreased satisfaction with treatment by the families, but similar QOL and less delusions and hallucinations than patients not prescribed clozapine. (C) 2015 Elsevier B.V. All rights reserved.